nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP3A5—prostate cancer	0.195	0.698	CbGaD
Domperidone—CYP3A4—prostate cancer	0.0845	0.302	CbGaD
Domperidone—CYP2C8—Nilutamide—prostate cancer	0.0247	0.0508	CbGbCtD
Domperidone—CYP3A5—Flutamide—prostate cancer	0.0213	0.0438	CbGbCtD
Domperidone—CYP2C8—Abiraterone—prostate cancer	0.0205	0.0421	CbGbCtD
Domperidone—CYP2B6—Estrone—prostate cancer	0.0196	0.0402	CbGbCtD
Domperidone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0191	0.0392	CbGbCtD
Domperidone—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0174	0.0358	CbGbCtD
Domperidone—CYP1A2—Flutamide—prostate cancer	0.0159	0.0326	CbGbCtD
Domperidone—CYP2D6—Bicalutamide—prostate cancer	0.0158	0.0324	CbGbCtD
Domperidone—CYP3A5—Cabazitaxel—prostate cancer	0.0158	0.0324	CbGbCtD
Domperidone—ABCB1—Estramustine—prostate cancer	0.0156	0.032	CbGbCtD
Domperidone—CYP3A5—Estrone—prostate cancer	0.0154	0.0317	CbGbCtD
Domperidone—CYP2C8—Cabazitaxel—prostate cancer	0.0152	0.0311	CbGbCtD
Domperidone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0132	0.0271	CbGbCtD
Domperidone—CYP2D6—Abiraterone—prostate cancer	0.0131	0.0268	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0118	0.0242	CbGbCtD
Domperidone—CYP3A7—Estradiol—prostate cancer	0.0118	0.0242	CbGbCtD
Domperidone—CYP1A2—Estrone—prostate cancer	0.0115	0.0236	CbGbCtD
Domperidone—ABCB1—Cabazitaxel—prostate cancer	0.0103	0.0211	CbGbCtD
Domperidone—CYP3A4—Bicalutamide—prostate cancer	0.01	0.0206	CbGbCtD
Domperidone—ABCB1—Estrone—prostate cancer	0.01	0.0206	CbGbCtD
Domperidone—CYP3A4—Estramustine—prostate cancer	0.00933	0.0192	CbGbCtD
Domperidone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00894	0.0184	CbGbCtD
Domperidone—CYP3A5—Estradiol—prostate cancer	0.00885	0.0182	CbGbCtD
Domperidone—CYP2C8—Estradiol—prostate cancer	0.00851	0.0175	CbGbCtD
Domperidone—CYP3A4—Abiraterone—prostate cancer	0.00831	0.0171	CbGbCtD
Domperidone—CYP3A4—Flutamide—prostate cancer	0.00831	0.0171	CbGbCtD
Domperidone—CYP1A2—Conjugated Estrogens—prostate cancer	0.0075	0.0154	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00705	0.0145	CbGbCtD
Domperidone—CYP3A7—Docetaxel—prostate cancer	0.00705	0.0145	CbGbCtD
Domperidone—CYP1A2—Estradiol—prostate cancer	0.00659	0.0135	CbGbCtD
Domperidone—ABCB1—Conjugated Estrogens—prostate cancer	0.00656	0.0135	CbGbCtD
Domperidone—CYP3A4—Cabazitaxel—prostate cancer	0.00615	0.0126	CbGbCtD
Domperidone—CYP3A4—Estrone—prostate cancer	0.00601	0.0123	CbGbCtD
Domperidone—ABCB1—Mitoxantrone—prostate cancer	0.00596	0.0123	CbGbCtD
Domperidone—CYP3A5—Etoposide—prostate cancer	0.00578	0.0119	CbGbCtD
Domperidone—ABCB1—Estradiol—prostate cancer	0.00576	0.0118	CbGbCtD
Domperidone—CYP2C8—Etoposide—prostate cancer	0.00556	0.0114	CbGbCtD
Domperidone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00536	0.011	CbGbCtD
Domperidone—CYP3A5—Docetaxel—prostate cancer	0.00529	0.0109	CbGbCtD
Domperidone—CYP2B6—Doxorubicin—prostate cancer	0.005	0.0103	CbGbCtD
Domperidone—ABCB1—Prednisone—prostate cancer	0.00495	0.0102	CbGbCtD
Domperidone—CYP1A2—Etoposide—prostate cancer	0.0043	0.00884	CbGbCtD
Domperidone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00393	0.00808	CbGbCtD
Domperidone—ABCB1—Etoposide—prostate cancer	0.00376	0.00773	CbGbCtD
Domperidone—CYP3A4—Mitoxantrone—prostate cancer	0.00357	0.00734	CbGbCtD
Domperidone—CYP3A4—Estradiol—prostate cancer	0.00345	0.00709	CbGbCtD
Domperidone—ABCB1—Docetaxel—prostate cancer	0.00344	0.00707	CbGbCtD
Domperidone—CYP3A4—Prednisone—prostate cancer	0.00297	0.0061	CbGbCtD
Domperidone—ABCB1—Doxorubicin—prostate cancer	0.00257	0.00527	CbGbCtD
Domperidone—CYP2D6—Doxorubicin—prostate cancer	0.00242	0.00497	CbGbCtD
Domperidone—CYP3A4—Etoposide—prostate cancer	0.00225	0.00463	CbGbCtD
Domperidone—CYP3A4—Docetaxel—prostate cancer	0.00206	0.00424	CbGbCtD
Domperidone—CYP3A4—Doxorubicin—prostate cancer	0.00154	0.00316	CbGbCtD
Domperidone—CYP1A2—urine—prostate cancer	0.000679	0.132	CbGeAlD
Domperidone—CYP3A4—urine—prostate cancer	0.000492	0.0957	CbGeAlD
Domperidone—CYP2D6—urine—prostate cancer	0.000484	0.0941	CbGeAlD
Domperidone—Perphenazine—AOX1—prostate cancer	0.000392	0.164	CrCbGaD
Domperidone—KCNH2—prostate gland—prostate cancer	0.000285	0.0554	CbGeAlD
Domperidone—KCNH2—seminal vesicle—prostate cancer	0.000241	0.0469	CbGeAlD
Domperidone—CYP3A5—prostate gland—prostate cancer	0.000235	0.0458	CbGeAlD
Domperidone—Pipotiazine—SLC22A1—prostate cancer	0.000209	0.0876	CrCbGaD
Domperidone—Pimozide—CYP3A5—prostate cancer	0.000196	0.082	CrCbGaD
Domperidone—Nefazodone—CYP3A5—prostate cancer	0.000195	0.0816	CrCbGaD
Domperidone—KCNH2—renal system—prostate cancer	0.000194	0.0378	CbGeAlD
Domperidone—KCNH2—urethra—prostate cancer	0.000191	0.0371	CbGeAlD
Domperidone—Palpitations—Conjugated Estrogens—prostate cancer	0.00019	0.00148	CcSEcCtD
Domperidone—Menopausal symptoms—Capecitabine—prostate cancer	0.000189	0.00147	CcSEcCtD
Domperidone—Vomiting—Cabazitaxel—prostate cancer	0.000188	0.00147	CcSEcCtD
Domperidone—Lethargy—Docetaxel—prostate cancer	0.000188	0.00146	CcSEcCtD
Domperidone—Thirst—Capecitabine—prostate cancer	0.000187	0.00145	CcSEcCtD
Domperidone—Nausea—Degarelix—prostate cancer	0.000187	0.00145	CcSEcCtD
Domperidone—Headache—Cabazitaxel—prostate cancer	0.000186	0.00144	CcSEcCtD
Domperidone—Constipation—Ethinyl Estradiol—prostate cancer	0.000184	0.00143	CcSEcCtD
Domperidone—Asthenia—Bicalutamide—prostate cancer	0.000182	0.00142	CcSEcCtD
Domperidone—Lethargy—Capecitabine—prostate cancer	0.000182	0.00141	CcSEcCtD
Domperidone—Breast pain—Doxorubicin—prostate cancer	0.000181	0.00141	CcSEcCtD
Domperidone—Migraine—Docetaxel—prostate cancer	0.000181	0.00141	CcSEcCtD
Domperidone—Dry mouth—Goserelin—prostate cancer	0.00018	0.0014	CcSEcCtD
Domperidone—Trazodone—CYP3A5—prostate cancer	0.00018	0.0755	CrCbGaD
Domperidone—Pruritus—Bicalutamide—prostate cancer	0.00018	0.0014	CcSEcCtD
Domperidone—CYP2C8—renal system—prostate cancer	0.000178	0.0346	CbGeAlD
Domperidone—Oedema—Goserelin—prostate cancer	0.000177	0.00138	CcSEcCtD
Domperidone—Nausea—Cabazitaxel—prostate cancer	0.000176	0.00137	CcSEcCtD
Domperidone—Perphenazine—CYP2C18—prostate cancer	0.000175	0.0734	CrCbGaD
Domperidone—Oedema—Conjugated Estrogens—prostate cancer	0.000175	0.00136	CcSEcCtD
Domperidone—Migraine—Capecitabine—prostate cancer	0.000175	0.00136	CcSEcCtD
Domperidone—Diarrhoea—Bicalutamide—prostate cancer	0.000174	0.00135	CcSEcCtD
Domperidone—Urticaria—Ethinyl Estradiol—prostate cancer	0.000171	0.00133	CcSEcCtD
Domperidone—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00017	0.00132	CcSEcCtD
Domperidone—Irritability—Capecitabine—prostate cancer	0.00017	0.00132	CcSEcCtD
Domperidone—Tension—Estradiol—prostate cancer	0.000169	0.00131	CcSEcCtD
Domperidone—Dizziness—Bicalutamide—prostate cancer	0.000168	0.00131	CcSEcCtD
Domperidone—Nervousness—Estradiol—prostate cancer	0.000167	0.0013	CcSEcCtD
Domperidone—CYP1A2—renal system—prostate cancer	0.000166	0.0323	CbGeAlD
Domperidone—Stomatitis—Etoposide—prostate cancer	0.000166	0.00129	CcSEcCtD
Domperidone—Hypotension—Goserelin—prostate cancer	0.000165	0.00129	CcSEcCtD
Domperidone—Muscle spasms—Estradiol—prostate cancer	0.000165	0.00128	CcSEcCtD
Domperidone—Arrhythmia—Mitoxantrone—prostate cancer	0.000164	0.00128	CcSEcCtD
Domperidone—Hypotension—Conjugated Estrogens—prostate cancer	0.000164	0.00127	CcSEcCtD
Domperidone—Lethargy—Prednisone—prostate cancer	0.000162	0.00126	CcSEcCtD
Domperidone—Vomiting—Bicalutamide—prostate cancer	0.000162	0.00126	CcSEcCtD
Domperidone—CYP3A5—renal system—prostate cancer	0.00016	0.0312	CbGeAlD
Domperidone—Rash—Bicalutamide—prostate cancer	0.00016	0.00125	CcSEcCtD
Domperidone—Dermatitis—Bicalutamide—prostate cancer	0.00016	0.00125	CcSEcCtD
Domperidone—Insomnia—Goserelin—prostate cancer	0.00016	0.00124	CcSEcCtD
Domperidone—CYP2B6—renal system—prostate cancer	0.000159	0.031	CbGeAlD
Domperidone—Headache—Bicalutamide—prostate cancer	0.000159	0.00124	CcSEcCtD
Domperidone—Insomnia—Conjugated Estrogens—prostate cancer	0.000158	0.00123	CcSEcCtD
Domperidone—Somnolence—Goserelin—prostate cancer	0.000157	0.00122	CcSEcCtD
Domperidone—Cramps of lower extremities—Epirubicin—prostate cancer	0.000157	0.00122	CcSEcCtD
Domperidone—Somnolence—Conjugated Estrogens—prostate cancer	0.000156	0.00121	CcSEcCtD
Domperidone—Dyspepsia—Goserelin—prostate cancer	0.000156	0.00121	CcSEcCtD
Domperidone—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000154	0.0012	CcSEcCtD
Domperidone—Asthenia—Ethinyl Estradiol—prostate cancer	0.000154	0.0012	CcSEcCtD
Domperidone—Pruritus—Ethinyl Estradiol—prostate cancer	0.000152	0.00118	CcSEcCtD
Domperidone—Palpitations—Estradiol—prostate cancer	0.000152	0.00118	CcSEcCtD
Domperidone—Irritability—Prednisone—prostate cancer	0.000151	0.00118	CcSEcCtD
Domperidone—Constipation—Goserelin—prostate cancer	0.000151	0.00118	CcSEcCtD
Domperidone—Nausea—Bicalutamide—prostate cancer	0.000151	0.00117	CcSEcCtD
Domperidone—Constipation—Conjugated Estrogens—prostate cancer	0.00015	0.00117	CcSEcCtD
Domperidone—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000147	0.00114	CcSEcCtD
Domperidone—KCNH2—bone marrow—prostate cancer	0.000147	0.0286	CbGeAlD
Domperidone—Cramps of lower extremities—Doxorubicin—prostate cancer	0.000145	0.00113	CcSEcCtD
Domperidone—Dysuria—Capecitabine—prostate cancer	0.000144	0.00112	CcSEcCtD
Domperidone—Dry mouth—Estradiol—prostate cancer	0.000143	0.00111	CcSEcCtD
Domperidone—Dizziness—Ethinyl Estradiol—prostate cancer	0.000142	0.00111	CcSEcCtD
Domperidone—Urticaria—Goserelin—prostate cancer	0.000141	0.00109	CcSEcCtD
Domperidone—Oedema—Estradiol—prostate cancer	0.00014	0.00109	CcSEcCtD
Domperidone—Abdominal pain—Goserelin—prostate cancer	0.00014	0.00109	CcSEcCtD
Domperidone—Urticaria—Conjugated Estrogens—prostate cancer	0.000139	0.00108	CcSEcCtD
Domperidone—Sertindole—CYP3A4—prostate cancer	0.000139	0.0583	CrCbGaD
Domperidone—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000139	0.00108	CcSEcCtD
Domperidone—Stomatitis—Docetaxel—prostate cancer	0.000138	0.00107	CcSEcCtD
Domperidone—Conjunctivitis—Docetaxel—prostate cancer	0.000138	0.00107	CcSEcCtD
Domperidone—Vomiting—Ethinyl Estradiol—prostate cancer	0.000137	0.00106	CcSEcCtD
Domperidone—Rash—Ethinyl Estradiol—prostate cancer	0.000136	0.00105	CcSEcCtD
Domperidone—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000135	0.00105	CcSEcCtD
Domperidone—Pimozide—CYP2E1—prostate cancer	0.000135	0.0564	CrCbGaD
Domperidone—Headache—Ethinyl Estradiol—prostate cancer	0.000135	0.00105	CcSEcCtD
Domperidone—Stomatitis—Capecitabine—prostate cancer	0.000134	0.00104	CcSEcCtD
Domperidone—Pimozide—CYP2C19—prostate cancer	0.000133	0.0558	CrCbGaD
Domperidone—Conjunctivitis—Capecitabine—prostate cancer	0.000133	0.00104	CcSEcCtD
Domperidone—Hot flush—Epirubicin—prostate cancer	0.000132	0.00103	CcSEcCtD
Domperidone—Menopausal symptoms—Epirubicin—prostate cancer	0.000131	0.00102	CcSEcCtD
Domperidone—Oedema—Mitoxantrone—prostate cancer	0.000131	0.00102	CcSEcCtD
Domperidone—Muscle spasms—Etoposide—prostate cancer	0.000128	0.000996	CcSEcCtD
Domperidone—Nausea—Ethinyl Estradiol—prostate cancer	0.000128	0.000993	CcSEcCtD
Domperidone—DRD2—testis—prostate cancer	0.000127	0.0248	CbGeAlD
Domperidone—Asthenia—Goserelin—prostate cancer	0.000127	0.000987	CcSEcCtD
Domperidone—Insomnia—Estradiol—prostate cancer	0.000127	0.000986	CcSEcCtD
Domperidone—Lethargy—Epirubicin—prostate cancer	0.000126	0.000984	CcSEcCtD
Domperidone—Asthenia—Conjugated Estrogens—prostate cancer	0.000126	0.000977	CcSEcCtD
Domperidone—KCNH2—testis—prostate cancer	0.000125	0.0244	CbGeAlD
Domperidone—Pruritus—Goserelin—prostate cancer	0.000125	0.000973	CcSEcCtD
Domperidone—ABCB1—prostate gland—prostate cancer	0.000125	0.0243	CbGeAlD
Domperidone—Somnolence—Estradiol—prostate cancer	0.000125	0.000969	CcSEcCtD
Domperidone—Pruritus—Conjugated Estrogens—prostate cancer	0.000124	0.000964	CcSEcCtD
Domperidone—Dyspepsia—Estradiol—prostate cancer	0.000123	0.00096	CcSEcCtD
Domperidone—Hot flush—Doxorubicin—prostate cancer	0.000123	0.000953	CcSEcCtD
Domperidone—Hypotension—Mitoxantrone—prostate cancer	0.000122	0.000949	CcSEcCtD
Domperidone—Migraine—Epirubicin—prostate cancer	0.000122	0.000949	CcSEcCtD
Domperidone—Menopausal symptoms—Doxorubicin—prostate cancer	0.000122	0.000945	CcSEcCtD
Domperidone—Diarrhoea—Goserelin—prostate cancer	0.000121	0.000941	CcSEcCtD
Domperidone—CYP3A4—renal system—prostate cancer	0.00012	0.0234	CbGeAlD
Domperidone—Constipation—Estradiol—prostate cancer	0.00012	0.000932	CcSEcCtD
Domperidone—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00012	0.000932	CcSEcCtD
Domperidone—CYP2D6—renal system—prostate cancer	0.000118	0.023	CbGeAlD
Domperidone—Lethargy—Doxorubicin—prostate cancer	0.000117	0.00091	CcSEcCtD
Domperidone—Dizziness—Goserelin—prostate cancer	0.000117	0.00091	CcSEcCtD
Domperidone—Somnolence—Mitoxantrone—prostate cancer	0.000116	0.000903	CcSEcCtD
Domperidone—Dizziness—Conjugated Estrogens—prostate cancer	0.000116	0.000901	CcSEcCtD
Domperidone—Dyspepsia—Mitoxantrone—prostate cancer	0.000115	0.000894	CcSEcCtD
Domperidone—Pipotiazine—CYP2C19—prostate cancer	0.000115	0.0481	CrCbGaD
Domperidone—CYP2C8—testis—prostate cancer	0.000115	0.0223	CbGeAlD
Domperidone—Arrhythmia—Docetaxel—prostate cancer	0.000114	0.000883	CcSEcCtD
Domperidone—Migraine—Doxorubicin—prostate cancer	0.000113	0.000878	CcSEcCtD
Domperidone—Vomiting—Goserelin—prostate cancer	0.000112	0.000875	CcSEcCtD
Domperidone—Constipation—Mitoxantrone—prostate cancer	0.000112	0.000869	CcSEcCtD
Domperidone—Rash—Goserelin—prostate cancer	0.000112	0.000867	CcSEcCtD
Domperidone—Dermatitis—Goserelin—prostate cancer	0.000111	0.000866	CcSEcCtD
Domperidone—Vomiting—Conjugated Estrogens—prostate cancer	0.000111	0.000866	CcSEcCtD
Domperidone—Urticaria—Estradiol—prostate cancer	0.000111	0.000866	CcSEcCtD
Domperidone—Abdominal pain—Estradiol—prostate cancer	0.000111	0.000862	CcSEcCtD
Domperidone—Headache—Goserelin—prostate cancer	0.000111	0.000862	CcSEcCtD
Domperidone—Rash—Conjugated Estrogens—prostate cancer	0.00011	0.000859	CcSEcCtD
Domperidone—Dermatitis—Conjugated Estrogens—prostate cancer	0.00011	0.000858	CcSEcCtD
Domperidone—Arrhythmia—Capecitabine—prostate cancer	0.00011	0.000855	CcSEcCtD
Domperidone—Headache—Conjugated Estrogens—prostate cancer	0.00011	0.000854	CcSEcCtD
Domperidone—Muscle spasms—Docetaxel—prostate cancer	0.000106	0.000827	CcSEcCtD
Domperidone—ABCB1—seminal vesicle—prostate cancer	0.000106	0.0206	CbGeAlD
Domperidone—Nausea—Goserelin—prostate cancer	0.000105	0.000817	CcSEcCtD
Domperidone—Nausea—Conjugated Estrogens—prostate cancer	0.000104	0.000809	CcSEcCtD
Domperidone—Urticaria—Mitoxantrone—prostate cancer	0.000104	0.000807	CcSEcCtD
Domperidone—Abdominal pain—Mitoxantrone—prostate cancer	0.000103	0.000803	CcSEcCtD
Domperidone—Muscle spasms—Capecitabine—prostate cancer	0.000103	0.000801	CcSEcCtD
Domperidone—CYP2B6—testis—prostate cancer	0.000103	0.02	CbGeAlD
Domperidone—Hypotension—Etoposide—prostate cancer	0.000102	0.00079	CcSEcCtD
Domperidone—Asthenia—Estradiol—prostate cancer	0.000101	0.000782	CcSEcCtD
Domperidone—Dysuria—Epirubicin—prostate cancer	0.0001	0.000779	CcSEcCtD
Domperidone—Pruritus—Estradiol—prostate cancer	9.92e-05	0.000771	CcSEcCtD
Domperidone—Pollakiuria—Epirubicin—prostate cancer	9.9e-05	0.00077	CcSEcCtD
Domperidone—Arrhythmia—Prednisone—prostate cancer	9.79e-05	0.000762	CcSEcCtD
Domperidone—Palpitations—Docetaxel—prostate cancer	9.78e-05	0.00076	CcSEcCtD
Domperidone—Somnolence—Etoposide—prostate cancer	9.66e-05	0.000751	CcSEcCtD
Domperidone—Diarrhoea—Estradiol—prostate cancer	9.59e-05	0.000746	CcSEcCtD
Domperidone—Drowsiness—Epirubicin—prostate cancer	9.55e-05	0.000743	CcSEcCtD
Domperidone—Palpitations—Capecitabine—prostate cancer	9.47e-05	0.000736	CcSEcCtD
Domperidone—Asthenia—Mitoxantrone—prostate cancer	9.37e-05	0.000729	CcSEcCtD
Domperidone—Stomatitis—Epirubicin—prostate cancer	9.31e-05	0.000724	CcSEcCtD
Domperidone—Constipation—Etoposide—prostate cancer	9.29e-05	0.000723	CcSEcCtD
Domperidone—Conjunctivitis—Epirubicin—prostate cancer	9.28e-05	0.000722	CcSEcCtD
Domperidone—Dizziness—Estradiol—prostate cancer	9.27e-05	0.000721	CcSEcCtD
Domperidone—Dysuria—Doxorubicin—prostate cancer	9.27e-05	0.000721	CcSEcCtD
Domperidone—Dry mouth—Docetaxel—prostate cancer	9.21e-05	0.000717	CcSEcCtD
Domperidone—ABCB1—epithelium—prostate cancer	9.18e-05	0.0179	CbGeAlD
Domperidone—Pollakiuria—Doxorubicin—prostate cancer	9.16e-05	0.000712	CcSEcCtD
Domperidone—KCNH2—lymph node—prostate cancer	9.1e-05	0.0177	CbGeAlD
Domperidone—Oedema—Docetaxel—prostate cancer	9.03e-05	0.000702	CcSEcCtD
Domperidone—Diarrhoea—Mitoxantrone—prostate cancer	8.94e-05	0.000695	CcSEcCtD
Domperidone—Dry mouth—Capecitabine—prostate cancer	8.92e-05	0.000694	CcSEcCtD
Domperidone—Vomiting—Estradiol—prostate cancer	8.92e-05	0.000693	CcSEcCtD
Domperidone—Rash—Estradiol—prostate cancer	8.84e-05	0.000688	CcSEcCtD
Domperidone—Drowsiness—Doxorubicin—prostate cancer	8.84e-05	0.000687	CcSEcCtD
Domperidone—Dermatitis—Estradiol—prostate cancer	8.83e-05	0.000687	CcSEcCtD
Domperidone—Headache—Estradiol—prostate cancer	8.78e-05	0.000683	CcSEcCtD
Domperidone—Oedema—Capecitabine—prostate cancer	8.74e-05	0.00068	CcSEcCtD
Domperidone—Urticaria—Etoposide—prostate cancer	8.63e-05	0.000671	CcSEcCtD
Domperidone—Stomatitis—Doxorubicin—prostate cancer	8.61e-05	0.00067	CcSEcCtD
Domperidone—Abdominal pain—Etoposide—prostate cancer	8.59e-05	0.000668	CcSEcCtD
Domperidone—Conjunctivitis—Doxorubicin—prostate cancer	8.59e-05	0.000668	CcSEcCtD
Domperidone—ABCB1—renal system—prostate cancer	8.52e-05	0.0166	CbGeAlD
Domperidone—Pimozide—CYP3A4—prostate cancer	8.48e-05	0.0355	CrCbGaD
Domperidone—Hypotension—Docetaxel—prostate cancer	8.44e-05	0.000656	CcSEcCtD
Domperidone—Nefazodone—CYP3A4—prostate cancer	8.43e-05	0.0353	CrCbGaD
Domperidone—ABCB1—urethra—prostate cancer	8.37e-05	0.0163	CbGeAlD
Domperidone—Nausea—Estradiol—prostate cancer	8.33e-05	0.000648	CcSEcCtD
Domperidone—Vomiting—Mitoxantrone—prostate cancer	8.31e-05	0.000646	CcSEcCtD
Domperidone—Rash—Mitoxantrone—prostate cancer	8.24e-05	0.000641	CcSEcCtD
Domperidone—Dermatitis—Mitoxantrone—prostate cancer	8.23e-05	0.00064	CcSEcCtD
Domperidone—Headache—Mitoxantrone—prostate cancer	8.19e-05	0.000636	CcSEcCtD
Domperidone—Hypotension—Capecitabine—prostate cancer	8.17e-05	0.000635	CcSEcCtD
Domperidone—Insomnia—Docetaxel—prostate cancer	8.17e-05	0.000635	CcSEcCtD
Domperidone—Somnolence—Docetaxel—prostate cancer	8.03e-05	0.000624	CcSEcCtD
Domperidone—Dyspepsia—Docetaxel—prostate cancer	7.95e-05	0.000618	CcSEcCtD
Domperidone—Insomnia—Capecitabine—prostate cancer	7.91e-05	0.000615	CcSEcCtD
Domperidone—Perphenazine—CYP2C19—prostate cancer	7.86e-05	0.0329	CrCbGaD
Domperidone—Trazodone—CYP3A4—prostate cancer	7.8e-05	0.0327	CrCbGaD
Domperidone—Asthenia—Etoposide—prostate cancer	7.8e-05	0.000606	CcSEcCtD
Domperidone—Oedema—Prednisone—prostate cancer	7.79e-05	0.000606	CcSEcCtD
Domperidone—Nausea—Mitoxantrone—prostate cancer	7.76e-05	0.000603	CcSEcCtD
Domperidone—Constipation—Docetaxel—prostate cancer	7.72e-05	0.000601	CcSEcCtD
Domperidone—Dyspepsia—Capecitabine—prostate cancer	7.7e-05	0.000599	CcSEcCtD
Domperidone—Pruritus—Etoposide—prostate cancer	7.69e-05	0.000598	CcSEcCtD
Domperidone—Arrhythmia—Epirubicin—prostate cancer	7.66e-05	0.000596	CcSEcCtD
Domperidone—CYP2D6—testis—prostate cancer	7.65e-05	0.0149	CbGeAlD
Domperidone—Constipation—Capecitabine—prostate cancer	7.48e-05	0.000581	CcSEcCtD
Domperidone—Diarrhoea—Etoposide—prostate cancer	7.44e-05	0.000578	CcSEcCtD
Domperidone—Tension—Epirubicin—prostate cancer	7.32e-05	0.00057	CcSEcCtD
Domperidone—Pipotiazine—CYP3A4—prostate cancer	7.31e-05	0.0306	CrCbGaD
Domperidone—Nervousness—Epirubicin—prostate cancer	7.25e-05	0.000564	CcSEcCtD
Domperidone—Dizziness—Etoposide—prostate cancer	7.19e-05	0.000559	CcSEcCtD
Domperidone—Muscle spasms—Epirubicin—prostate cancer	7.18e-05	0.000558	CcSEcCtD
Domperidone—Abdominal pain—Docetaxel—prostate cancer	7.14e-05	0.000555	CcSEcCtD
Domperidone—Arrhythmia—Doxorubicin—prostate cancer	7.09e-05	0.000551	CcSEcCtD
Domperidone—Insomnia—Prednisone—prostate cancer	7.05e-05	0.000548	CcSEcCtD
Domperidone—Prochlorperazine—CYP3A4—prostate cancer	6.99e-05	0.0293	CrCbGaD
Domperidone—Urticaria—Capecitabine—prostate cancer	6.95e-05	0.00054	CcSEcCtD
Domperidone—Abdominal pain—Capecitabine—prostate cancer	6.91e-05	0.000538	CcSEcCtD
Domperidone—Vomiting—Etoposide—prostate cancer	6.91e-05	0.000537	CcSEcCtD
Domperidone—Dyspepsia—Prednisone—prostate cancer	6.86e-05	0.000533	CcSEcCtD
Domperidone—Rash—Etoposide—prostate cancer	6.85e-05	0.000533	CcSEcCtD
Domperidone—Dermatitis—Etoposide—prostate cancer	6.85e-05	0.000532	CcSEcCtD
Domperidone—Headache—Etoposide—prostate cancer	6.81e-05	0.000529	CcSEcCtD
Domperidone—Tension—Doxorubicin—prostate cancer	6.78e-05	0.000527	CcSEcCtD
Domperidone—Nervousness—Doxorubicin—prostate cancer	6.71e-05	0.000522	CcSEcCtD
Domperidone—Constipation—Prednisone—prostate cancer	6.66e-05	0.000518	CcSEcCtD
Domperidone—Muscle spasms—Doxorubicin—prostate cancer	6.64e-05	0.000516	CcSEcCtD
Domperidone—Palpitations—Epirubicin—prostate cancer	6.6e-05	0.000513	CcSEcCtD
Domperidone—Asthenia—Docetaxel—prostate cancer	6.48e-05	0.000504	CcSEcCtD
Domperidone—Nausea—Etoposide—prostate cancer	6.46e-05	0.000502	CcSEcCtD
Domperidone—ABCB1—bone marrow—prostate cancer	6.44e-05	0.0125	CbGeAlD
Domperidone—Pruritus—Docetaxel—prostate cancer	6.39e-05	0.000497	CcSEcCtD
Domperidone—Asthenia—Capecitabine—prostate cancer	6.27e-05	0.000488	CcSEcCtD
Domperidone—Dry mouth—Epirubicin—prostate cancer	6.22e-05	0.000483	CcSEcCtD
Domperidone—Urticaria—Prednisone—prostate cancer	6.19e-05	0.000481	CcSEcCtD
Domperidone—Pruritus—Capecitabine—prostate cancer	6.19e-05	0.000481	CcSEcCtD
Domperidone—Diarrhoea—Docetaxel—prostate cancer	6.18e-05	0.000481	CcSEcCtD
Domperidone—Abdominal pain—Prednisone—prostate cancer	6.16e-05	0.000479	CcSEcCtD
Domperidone—Palpitations—Doxorubicin—prostate cancer	6.1e-05	0.000475	CcSEcCtD
Domperidone—Oedema—Epirubicin—prostate cancer	6.09e-05	0.000474	CcSEcCtD
Domperidone—Diarrhoea—Capecitabine—prostate cancer	5.98e-05	0.000465	CcSEcCtD
Domperidone—Dizziness—Docetaxel—prostate cancer	5.97e-05	0.000464	CcSEcCtD
Domperidone—Dizziness—Capecitabine—prostate cancer	5.78e-05	0.00045	CcSEcCtD
Domperidone—Dry mouth—Doxorubicin—prostate cancer	5.75e-05	0.000447	CcSEcCtD
Domperidone—Vomiting—Docetaxel—prostate cancer	5.74e-05	0.000447	CcSEcCtD
Domperidone—Rash—Docetaxel—prostate cancer	5.69e-05	0.000443	CcSEcCtD
Domperidone—Hypotension—Epirubicin—prostate cancer	5.69e-05	0.000443	CcSEcCtD
Domperidone—Dermatitis—Docetaxel—prostate cancer	5.69e-05	0.000442	CcSEcCtD
Domperidone—Headache—Docetaxel—prostate cancer	5.66e-05	0.00044	CcSEcCtD
Domperidone—Oedema—Doxorubicin—prostate cancer	5.64e-05	0.000438	CcSEcCtD
Domperidone—Asthenia—Prednisone—prostate cancer	5.59e-05	0.000435	CcSEcCtD
Domperidone—Vomiting—Capecitabine—prostate cancer	5.56e-05	0.000432	CcSEcCtD
Domperidone—Rash—Capecitabine—prostate cancer	5.51e-05	0.000429	CcSEcCtD
Domperidone—Pruritus—Prednisone—prostate cancer	5.51e-05	0.000429	CcSEcCtD
Domperidone—Insomnia—Epirubicin—prostate cancer	5.51e-05	0.000428	CcSEcCtD
Domperidone—Dermatitis—Capecitabine—prostate cancer	5.51e-05	0.000428	CcSEcCtD
Domperidone—ABCB1—testis—prostate cancer	5.51e-05	0.0107	CbGeAlD
Domperidone—Headache—Capecitabine—prostate cancer	5.48e-05	0.000426	CcSEcCtD
Domperidone—Somnolence—Epirubicin—prostate cancer	5.42e-05	0.000421	CcSEcCtD
Domperidone—Nausea—Docetaxel—prostate cancer	5.36e-05	0.000417	CcSEcCtD
Domperidone—Dyspepsia—Epirubicin—prostate cancer	5.36e-05	0.000417	CcSEcCtD
Domperidone—Diarrhoea—Prednisone—prostate cancer	5.33e-05	0.000414	CcSEcCtD
Domperidone—Hypotension—Doxorubicin—prostate cancer	5.27e-05	0.00041	CcSEcCtD
Domperidone—Constipation—Epirubicin—prostate cancer	5.21e-05	0.000405	CcSEcCtD
Domperidone—Nausea—Capecitabine—prostate cancer	5.19e-05	0.000404	CcSEcCtD
Domperidone—Dizziness—Prednisone—prostate cancer	5.15e-05	0.000401	CcSEcCtD
Domperidone—Insomnia—Doxorubicin—prostate cancer	5.1e-05	0.000396	CcSEcCtD
Domperidone—Somnolence—Doxorubicin—prostate cancer	5.01e-05	0.00039	CcSEcCtD
Domperidone—Perphenazine—CYP3A4—prostate cancer	5e-05	0.0209	CrCbGaD
Domperidone—Dyspepsia—Doxorubicin—prostate cancer	4.96e-05	0.000386	CcSEcCtD
Domperidone—Vomiting—Prednisone—prostate cancer	4.95e-05	0.000385	CcSEcCtD
Domperidone—Rash—Prednisone—prostate cancer	4.91e-05	0.000382	CcSEcCtD
Domperidone—Dermatitis—Prednisone—prostate cancer	4.91e-05	0.000382	CcSEcCtD
Domperidone—Headache—Prednisone—prostate cancer	4.88e-05	0.000379	CcSEcCtD
Domperidone—Urticaria—Epirubicin—prostate cancer	4.84e-05	0.000376	CcSEcCtD
Domperidone—Constipation—Doxorubicin—prostate cancer	4.82e-05	0.000375	CcSEcCtD
Domperidone—Abdominal pain—Epirubicin—prostate cancer	4.82e-05	0.000374	CcSEcCtD
Domperidone—Nausea—Prednisone—prostate cancer	4.63e-05	0.00036	CcSEcCtD
Domperidone—Urticaria—Doxorubicin—prostate cancer	4.48e-05	0.000348	CcSEcCtD
Domperidone—Abdominal pain—Doxorubicin—prostate cancer	4.46e-05	0.000346	CcSEcCtD
Domperidone—Asthenia—Epirubicin—prostate cancer	4.37e-05	0.00034	CcSEcCtD
Domperidone—Pruritus—Epirubicin—prostate cancer	4.31e-05	0.000335	CcSEcCtD
Domperidone—Diarrhoea—Epirubicin—prostate cancer	4.17e-05	0.000324	CcSEcCtD
Domperidone—Asthenia—Doxorubicin—prostate cancer	4.04e-05	0.000314	CcSEcCtD
Domperidone—Dizziness—Epirubicin—prostate cancer	4.03e-05	0.000313	CcSEcCtD
Domperidone—ABCB1—lymph node—prostate cancer	3.99e-05	0.00776	CbGeAlD
Domperidone—Pruritus—Doxorubicin—prostate cancer	3.99e-05	0.00031	CcSEcCtD
Domperidone—Vomiting—Epirubicin—prostate cancer	3.87e-05	0.000301	CcSEcCtD
Domperidone—Diarrhoea—Doxorubicin—prostate cancer	3.86e-05	0.0003	CcSEcCtD
Domperidone—Rash—Epirubicin—prostate cancer	3.84e-05	0.000299	CcSEcCtD
Domperidone—Dermatitis—Epirubicin—prostate cancer	3.84e-05	0.000298	CcSEcCtD
Domperidone—Headache—Epirubicin—prostate cancer	3.82e-05	0.000297	CcSEcCtD
Domperidone—Dizziness—Doxorubicin—prostate cancer	3.73e-05	0.00029	CcSEcCtD
Domperidone—Nausea—Epirubicin—prostate cancer	3.62e-05	0.000281	CcSEcCtD
Domperidone—Vomiting—Doxorubicin—prostate cancer	3.58e-05	0.000279	CcSEcCtD
Domperidone—Rash—Doxorubicin—prostate cancer	3.55e-05	0.000276	CcSEcCtD
Domperidone—Dermatitis—Doxorubicin—prostate cancer	3.55e-05	0.000276	CcSEcCtD
Domperidone—Headache—Doxorubicin—prostate cancer	3.53e-05	0.000275	CcSEcCtD
Domperidone—Nausea—Doxorubicin—prostate cancer	3.35e-05	0.00026	CcSEcCtD
Domperidone—DRD2—Signaling Pathways—CAV1—prostate cancer	2.55e-06	2.62e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MED12—prostate cancer	2.53e-06	2.6e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—COMT—prostate cancer	2.53e-06	2.6e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KDR—prostate cancer	2.52e-06	2.59e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—prostate cancer	2.52e-06	2.59e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.52e-06	2.59e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOS3—prostate cancer	2.52e-06	2.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNG5—prostate cancer	2.51e-06	2.58e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CAV1—prostate cancer	2.5e-06	2.57e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ERCC2—prostate cancer	2.5e-06	2.57e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.5e-06	2.57e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ITPR1—prostate cancer	2.48e-06	2.55e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—RXRA—prostate cancer	2.48e-06	2.55e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ESR1—prostate cancer	2.46e-06	2.53e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JAK2—prostate cancer	2.45e-06	2.52e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.44e-06	2.51e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.42e-06	2.49e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.41e-06	2.48e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NQO1—prostate cancer	2.41e-06	2.48e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—prostate cancer	2.4e-06	2.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BAD—prostate cancer	2.4e-06	2.47e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—prostate cancer	2.39e-06	2.46e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MDM2—prostate cancer	2.39e-06	2.46e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—COMT—prostate cancer	2.39e-06	2.45e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TH—prostate cancer	2.38e-06	2.44e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—prostate cancer	2.37e-06	2.44e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.36e-06	2.43e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—prostate cancer	2.36e-06	2.42e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MTHFR—prostate cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—TYMS—prostate cancer	2.34e-06	2.41e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.34e-06	2.41e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ITPR1—prostate cancer	2.34e-06	2.4e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.33e-06	2.4e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CB—prostate cancer	2.33e-06	2.39e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—prostate cancer	2.32e-06	2.39e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APC—prostate cancer	2.32e-06	2.39e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—prostate cancer	2.31e-06	2.38e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.31e-06	2.38e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.31e-06	2.37e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARA—prostate cancer	2.3e-06	2.37e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IRS1—prostate cancer	2.3e-06	2.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGF—prostate cancer	2.3e-06	2.36e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.29e-06	2.36e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.28e-06	2.34e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—LPL—prostate cancer	2.27e-06	2.34e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ACHE—prostate cancer	2.24e-06	2.3e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.24e-06	2.3e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GGT1—prostate cancer	2.24e-06	2.3e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—prostate cancer	2.23e-06	2.3e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GSK3B—prostate cancer	2.23e-06	2.29e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.21e-06	2.28e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—TYMS—prostate cancer	2.21e-06	2.27e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—INS—prostate cancer	2.21e-06	2.27e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NCOA1—prostate cancer	2.21e-06	2.27e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—INS—prostate cancer	2.2e-06	2.26e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A1—prostate cancer	2.19e-06	2.26e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1B—prostate cancer	2.18e-06	2.24e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—prostate cancer	2.18e-06	2.24e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ERCC2—prostate cancer	2.18e-06	2.24e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.17e-06	2.24e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CAV1—prostate cancer	2.17e-06	2.23e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CREBBP—prostate cancer	2.16e-06	2.22e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—prostate cancer	2.16e-06	2.22e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—INS—prostate cancer	2.16e-06	2.22e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.15e-06	2.21e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CREBBP—prostate cancer	2.15e-06	2.21e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—LPL—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CASP3—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1—prostate cancer	2.13e-06	2.19e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—prostate cancer	2.12e-06	2.19e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.12e-06	2.18e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—prostate cancer	2.12e-06	2.18e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CREBBP—prostate cancer	2.11e-06	2.17e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—RXRA—prostate cancer	2.1e-06	2.16e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—prostate cancer	2.09e-06	2.15e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—prostate cancer	2.08e-06	2.14e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.07e-06	2.13e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.07e-06	2.13e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CTNNB1—prostate cancer	2.06e-06	2.12e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAP2K1—prostate cancer	2.05e-06	2.11e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ERCC2—prostate cancer	2.05e-06	2.11e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.05e-06	2.11e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MTHFR—prostate cancer	2.05e-06	2.1e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CD—prostate cancer	2.04e-06	2.1e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.04e-06	2.1e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—prostate cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—COMT—prostate cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SERPINE1—prostate cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1A—prostate cancer	2.01e-06	2.07e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—prostate cancer	2.01e-06	2.07e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—prostate cancer	2.01e-06	2.07e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARA—prostate cancer	2.01e-06	2.06e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CD—prostate cancer	2e-06	2.06e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—prostate cancer	2e-06	2.06e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—EP300—prostate cancer	1.99e-06	2.05e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ITPR1—prostate cancer	1.98e-06	2.04e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.97e-06	2.03e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—prostate cancer	1.96e-06	2.02e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGF2—prostate cancer	1.95e-06	2.01e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.95e-06	2e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NOS3—prostate cancer	1.93e-06	1.99e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.93e-06	1.98e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOS3—prostate cancer	1.93e-06	1.98e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.93e-06	1.98e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EP300—prostate cancer	1.92e-06	1.97e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARA—prostate cancer	1.89e-06	1.95e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NOS3—prostate cancer	1.89e-06	1.95e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CAV1—prostate cancer	1.89e-06	1.94e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.88e-06	1.94e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JAK2—prostate cancer	1.87e-06	1.93e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TYMS—prostate cancer	1.87e-06	1.92e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—INS—prostate cancer	1.87e-06	1.92e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SRC—prostate cancer	1.86e-06	1.92e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NQO1—prostate cancer	1.86e-06	1.91e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—prostate cancer	1.85e-06	1.9e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	1.84e-06	1.89e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TH—prostate cancer	1.83e-06	1.89e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CREBBP—prostate cancer	1.83e-06	1.88e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MDM2—prostate cancer	1.83e-06	1.88e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—prostate cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LPL—prostate cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.8e-06	1.85e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—prostate cancer	1.8e-06	1.85e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.79e-06	1.84e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.78e-06	1.84e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.78e-06	1.83e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CAV1—prostate cancer	1.78e-06	1.83e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—prostate cancer	1.77e-06	1.82e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.75e-06	1.8e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.75e-06	1.8e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ERCC2—prostate cancer	1.74e-06	1.79e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.73e-06	1.78e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—prostate cancer	1.73e-06	1.78e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GGT1—prostate cancer	1.73e-06	1.78e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.72e-06	1.77e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.71e-06	1.76e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.7e-06	1.75e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.68e-06	1.73e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.67e-06	1.72e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—prostate cancer	1.67e-06	1.72e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFB1—prostate cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.65e-06	1.7e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NOS3—prostate cancer	1.64e-06	1.68e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CASP3—prostate cancer	1.64e-06	1.68e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—prostate cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MTHFR—prostate cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—prostate cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—INS—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.62e-06	1.67e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—RXRA—prostate cancer	1.62e-06	1.67e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARA—prostate cancer	1.6e-06	1.65e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CREBBP—prostate cancer	1.59e-06	1.64e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—prostate cancer	1.59e-06	1.64e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.58e-06	1.62e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—COMT—prostate cancer	1.56e-06	1.6e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.55e-06	1.6e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—prostate cancer	1.55e-06	1.59e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—prostate cancer	1.54e-06	1.59e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—prostate cancer	1.54e-06	1.59e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.54e-06	1.59e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—prostate cancer	1.54e-06	1.58e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—INS—prostate cancer	1.53e-06	1.58e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.53e-06	1.57e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.51e-06	1.56e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.51e-06	1.55e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—prostate cancer	1.51e-06	1.55e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CAV1—prostate cancer	1.51e-06	1.55e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.5e-06	1.55e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.5e-06	1.54e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—prostate cancer	1.5e-06	1.54e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—EP300—prostate cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EP300—prostate cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TYMS—prostate cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—EP300—prostate cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NOS3—prostate cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SRC—prostate cancer	1.43e-06	1.47e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LPL—prostate cancer	1.4e-06	1.44e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.39e-06	1.43e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—prostate cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—prostate cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NOS3—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—prostate cancer	1.31e-06	1.34e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—prostate cancer	1.31e-06	1.34e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—INS—prostate cancer	1.3e-06	1.34e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—prostate cancer	1.28e-06	1.31e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CREBBP—prostate cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—prostate cancer	1.26e-06	1.29e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—prostate cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—EP300—prostate cancer	1.25e-06	1.28e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARA—prostate cancer	1.24e-06	1.27e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.21e-06	1.24e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—prostate cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—prostate cancer	1.18e-06	1.21e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CAV1—prostate cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—prostate cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NOS3—prostate cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—prostate cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—EP300—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—prostate cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—prostate cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—prostate cancer	1.04e-06	1.07e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—EP300—prostate cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—INS—prostate cancer	1e-06	1.03e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CREBBP—prostate cancer	9.82e-07	1.01e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—prostate cancer	9.6e-07	9.88e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.31e-07	9.58e-06	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—prostate cancer	9.22e-07	9.48e-06	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—prostate cancer	9.09e-07	9.35e-06	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—prostate cancer	8.89e-07	9.15e-06	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—prostate cancer	8.86e-07	9.12e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NOS3—prostate cancer	8.79e-07	9.04e-06	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—prostate cancer	8.69e-07	8.94e-06	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—EP300—prostate cancer	8.67e-07	8.91e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.11e-07	8.35e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—prostate cancer	8.04e-07	8.27e-06	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—prostate cancer	8.03e-07	8.26e-06	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.57e-07	7.78e-06	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—prostate cancer	7.53e-07	7.75e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—prostate cancer	7.01e-07	7.21e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—EP300—prostate cancer	6.69e-07	6.88e-06	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—prostate cancer	6.56e-07	6.75e-06	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.41e-07	6.59e-06	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—prostate cancer	6.18e-07	6.36e-06	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—prostate cancer	5.24e-07	5.39e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.95e-07	5.09e-06	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—prostate cancer	4.04e-07	4.16e-06	CbGpPWpGaD
